featured
Long-Term Retinal Vasculature Abnormalities Following Intravitreal Bevacizumab for ROP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Graefe's Archive for Clinical and Experimental Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term retinal vasculature abnormalities following intravitreal bevacizumab for retinopathy of prematurity
Graefes Arch. Clin. Exp. Ophthalmol 2022 Jun 01;260(6)1915-1921, A Sternfeld, S Rahmani, JL Rossen, DL Zhang, YD Li, VL Quan, R Huang, HH YoonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.